<SEC-DOCUMENT>0001127602-25-011849.txt : 20250409
<SEC-HEADER>0001127602-25-011849.hdr.sgml : 20250409
<ACCEPTANCE-DATETIME>20250409161453
ACCESSION NUMBER:		0001127602-25-011849
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20250407
FILED AS OF DATE:		20250409
DATE AS OF CHANGE:		20250409

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Chan Frank
		CENTRAL INDEX KEY:			0002061743
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14041
		FILM NUMBER:		25825358

	MAIL ADDRESS:	
		STREET 1:		125 SUMMER ST.
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HAEMONETICS CORP
		CENTRAL INDEX KEY:			0000313143
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				042882273
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0329

	BUSINESS ADDRESS:	
		STREET 1:		125 SUMMER STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		7818487100

	MAIL ADDRESS:	
		STREET 1:		125 SUMMER STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>form3.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2025-04-07</periodOfReport>

    <noSecuritiesOwned>1</noSecuritiesOwned>

    <issuer>
        <issuerCik>0000313143</issuerCik>
        <issuerName>HAEMONETICS CORP</issuerName>
        <issuerTradingSymbol>HAE</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0002061743</rptOwnerCik>
            <rptOwnerName>Chan Frank</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>125 SUMMER STREET</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>BOSTON</rptOwnerCity>
            <rptOwnerState>MA</rptOwnerState>
            <rptOwnerZipCode>02110</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isOfficer>1</isOfficer>
            <officerTitle>EVP, Chief Operating Officer</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <footnotes></footnotes>

    <ownerSignature>
        <signatureName>/s/ Thomas V. Powers, attorney-in-fact for Mr. Chan</signatureName>
        <signatureDate>2025-04-09</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>doc1.txt
<DESCRIPTION>POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY
<TEXT>
POWER OF ATTORNEY
For Executing SEC Securities Transaction Forms

Know all persons by these presents that the undersigned hereby constitutes and
appoints each of Michelle L. Basil and Thomas V. Powers, signing singly, the
undersigned?s true and lawful attorney-i n-fact to:

(1) execute for and on behalf of the undersigned, in the undersigned?s capacity
as an officer and/or director of Haemonetics Corporation (the ?Company?), Forms
3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of
1934 and the rules thereunder and such other forms as may be required by the
United States Securities and Exchange Commission (the ?SEC?) relating to
transactions by the undersigned in securities issued by the Company (?Forms?);

(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete the execution of any such Forms,
complete and execute an amendment or amendments thereto, and timely file such
Forms with the SEC and any other appropriate governmental authority; and

(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney shall be in such form and
shall contain such terms and conditions as such attorney-in-fact may approve in
such attorney-in-fact?s discretion.

The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform all and every act and thing whatsoever requisite,
necessary and proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact?s substitute or substitutes, shall lawfully do or cause
to be done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-infact, in
serving in such capacity at the request of the undersigned, are not assuming
any of the undersigned?s responsibilities to comply with Section 16 of the
Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file the Forms with respect to the
undersigned?s holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused his/her Power of Attorney to be
executed as of March 14, 2025.


/s/ Frank Chan
Signature
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
